Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Who is novosanis
Latest news
Novosanis acquired by OraSure Technologies Inc
8/01/2019
Wijnegem, Belgium, January 8, 2019: Novosanis, a privately-held, Belgian company founded as a spinoff company from the University of Antwerp, Belgium, in 2013, annouced today that it has been acquired by the US-based publicly traded company OraSure Technologies Inc. (Bethlehem, PA, US; NASDAQ: OSUR...
Upcoming event
There are no events associated with this category.
Events
Regulatory
Team
News